switching from mounjaro to semaglutide Wegovy Switching from Wegovy to Mounjaro

A 2024 study published in JAMA Ophthalmology reported that patients with Type 2 diabetes who took semaglutide-containing medications had more than a fourfold higher risk for developing non-arteritic anterior ischemic optic neuropathy (NAION) compared with patients not on a GLP-1 agonist

Descargo de responsabilidad: Este artculo es solo para fines informativos y no constituye consejo mdico

This mindful approach supports both appetite suppression and overall health

While healthy lifestyle changes remain a cornerstone of our approach, semaglutide GLP-1 provides an advanced option that targets the underlying physiological drivers of obesity, offering our patients a real opportunity to reset their weight set point and achieve lasting results

WADA-prohibited in competitive sport, with no therapeutic-use exemption available